Anders Svenningsson
Anders Svenningsson
Verified email at
Cited by
Cited by
An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study
P Sundström, P Juto, G Wadell, G Hallmans, A Svenningsson, L Nyström, ...
Neurology 62 (12), 2277-2282, 2004
Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells
H Hammarberg, O Lidman, C Lundberg, SY Eltayeb, AW Gielen, ...
Journal of Neuroscience 20 (14), 5283-5291, 2000
Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab
M Gunnarsson, C Malmeström, M Axelsson, P Sundström, C Dahle, ...
Annals of neurology 69 (1), 83-89, 2011
Rituximab in multiple sclerosis: a retrospective observational study on safety and efficacy
J Salzer, R Svenningsson, P Alping, L Novakova, A Björck, K Fink, ...
Neurology 87 (20), 2074-2081, 2016
Monitoring disease activity in multiple sclerosis using serum neurofilament light protein
L Novakova, H Zetterberg, P Sundström, M Axelsson, M Khademi, ...
Neurology 89 (22), 2230-2237, 2017
Neurofilament and glial fibrillary acidic protein in multiple sclerosis
N Norgren, P Sundström, A Svenningsson, L Rosengren, T Stigbrand, ...
Neurology 63 (9), 1586-1590, 2004
Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis
C Bridel, WN Van Wieringen, H Zetterberg, BM Tijms, CE Teunissen, ...
JAMA neurology 76 (9), 1035-1048, 2019
Alemtuzumab CARE-MS II 5-year follow-up: efficacy and safety findings
AJ Coles, JA Cohen, EJ Fox, G Giovannoni, HP Hartung, E Havrdova, ...
Neurology 89 (11), 1117-1126, 2017
Infection risks among patients with multiple sclerosis treated with fingolimod, natalizumab, rituximab, and injectable therapies
G Luna, P Alping, J Burman, K Fink, A Fogdell-Hahn, M Gunnarsson, ...
JAMA neurology 77 (2), 184-191, 2020
Neurofilament light as a prognostic marker in multiple sclerosis
J Salzer, A Svenningsson, P Sundström
Multiple Sclerosis Journal 16 (3), 287-292, 2010
Rituximab versus fingolimod after natalizumab in multiple sclerosis patients
P Alping, T Frisell, L Novakova, P Islam‐Jakobsson, J Salzer, A Björck, ...
Annals of neurology 79 (6), 950-958, 2016
Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience
J Burman, E Iacobaeus, A Svenningsson, J Lycke, M Gunnarsson, ...
Journal of Neurology, Neurosurgery & Psychiatry 85 (10), 1116-1121, 2014
Alemtuzumab CARE-MS I 5-year follow-up: durable efficacy in the absence of continuous MS therapy
E Havrdova, DL Arnold, JA Cohen, HP Hartung, EJ Fox, G Giovannoni, ...
Neurology 89 (11), 1107-1116, 2017
Lymphocyte phenotype and subset distribution in normal cerebrospinal fluid
A Svenningsson, O Andersen, M Edsbagge, S Stemme
Journal of neuroimmunology 63 (1), 39-46, 1995
Adhesion molecule expression on cerebrospinal fluid T lymphocytes: evidence for common recruitment mechanisms in multiple sclerosis, aseptic meningitis, and normal controls
A Svenningsson, GK Hansson, O Andersen, R Andersson, M Patarroyo, ...
Annals of Neurology: Official Journal of the American Neurological …, 1993
Incidence of MS during two fifteen‐year periods in the Gothenburg region of Sweden
A Svenningsson, B Runmarker, J Lycke, O Andersen
Acta neurologica scandinavica 82 (3), 161-168, 1990
Linomide reduces the rate of active lesions in relapsing-remitting multiple sclerosis
O Andersen, J Lycke, PO Tollesson, A Svenningsson, B Runmarker, ...
Neurology 47 (4), 895-900, 1996
Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosis
M Axelsson, C Malmeström, M Gunnarsson, H Zetterberg, P Sundström, ...
Multiple Sclerosis Journal 20 (1), 43-50, 2014
Comparative effectiveness of rituximab and other initial treatment choices for multiple sclerosis
M Granqvist, M Boremalm, A Poorghobad, A Svenningsson, J Salzer, ...
JAMA neurology 75 (3), 320-327, 2018
A Swedish national post-marketing surveillance study of natalizumab treatment in multiple sclerosis
C Holmen, F Piehl, J Hillert, A Fogdell-Hahn, M Lundkvist, E Karlberg, ...
Multiple Sclerosis Journal 17 (6), 708-719, 2011
The system can't perform the operation now. Try again later.
Articles 1–20